- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Novartis' spending on research and development by division 2017-2018
Novartis' spending on research and development by division 2017-2018
Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Jan 30, 2019
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from in 2017 and 2018, by business segment. In both years, the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division.
Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)
Loading statistic...
| 2017 | 2018 | |
|---|---|---|
| Innovative Medicines | 7.62 | 7.68 |
| Sandoz | 0.77 | 0.81 |
| Alcon | 0.58 | 0.59 |
| 2017 | 2018 | |
|---|---|---|
| Innovative Medicines | 7.62 | 7.68 |
| Sandoz | 0.77 | 0.81 |
| Alcon | 0.58 | 0.59 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jan 30, 2019
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from in 2017 and 2018, by business segment. In both years, the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division.
- Show sources information
- Show publisher information
- Release date
- January 2019
- Region
- Worldwide
- Survey time period
- 2017 and 2018
- Supplementary notes
- All figures are rounded.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- Worldwide
- Survey time period
- 2017 and 2018
- Supplementary notes
- All figures are rounded.
- Open this statistic in...
Other statistics on the topic
Novartis
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Novartis' top drugs based on revenue 2018
+Pharmaceutical Products & Market
R&D spending share of top pharmaceutical companies 2018 and 2024
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Novartis
- 46 page/s
- English
- pptx
- Detailed references
Everything On "Novartis" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Novartis"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*R&D spending share of top pharmaceutical companies 2018 and 2024
- Net profit per employee of global top 20 pharmaceutical companies in 2018 (in 1,000 U.S. dollars)Net profit generated per employee in top pharmaceutical companies 2018
- Company overview
The most important statistics
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)Novartis' net income 2007-2018
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)Dividends paid by Novartis AG 2009-2018
- Total number of Novartis AG's full-time employees from 2009 to 2018*Novartis' number of full-time employees 2009-2018
- Revenue distribution
The most important statistics
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)Novartis' revenue by region 2016-2018
- Percentage of Novartis AG's revenue in 2018, by segment and market*Novartis - revenue 2018 by segment and market
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*Percentage of Novartis pharmaceuticals revenue by therapy area 2018
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)Novartis' top drugs based on revenue 2018
- Research and development
The most important statistics
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)Novartis' expenditure on research and development 2004-2018
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018Novartis' R&D expenditure as a percent of revenue 2004-2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)Novartis' spending on research and development by division 2017-2018
- Miscellaneous
The most important statistics
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)Patients reached by Novartis AG's products 2009-2018
- Novartis advertising spending in the United States from 2012 to 2018 (in million U.S. dollars)Novartis: ad spend in the U.S. 2012-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Novartis' sales revenue in Spain 2012-2017
- Novartis' number of full-time employees by division 2013-2014
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by region
- Italy: clinical trials of Novartis approved by AIFA 2017, by stage
- Italy: investments of Novartis 2013-2017
- Italy: number of employees of Novartis 2017, by region
- Value of Novartis' pharmaceuticals exported from Spain 2012-2016
- Value of Novartis' investment in Spain 2012-2016
- Novartis' number of employees in Spain 2012-2017
- Novartis' R & D expenditure in Spain 2012-2016
- Genetic drugs: percentage of patents worldwide 2010
- LabCorp operating income 2013-2018
- Genentech: U.S. revenue by product 2008
- Remuneration of executive directors at GSK Pharmaceuticals in India FY 2018
- Software-defined storage market revenue 2016-2022
- Share in world imports of the leading food importers 2014, by country
Studies
- Biotechnology Industry in Europe
- Pharmaceutical industry in Italy
- Putting the Science back into Life Sciences
- Unleashing Pharma from the R&D Value Chain
- 2019 PhRMA Annual Membership Survey
- California Life Sciences Industry Report 2019
- The 2019 Genentech Oncology Trend Report
- 2019 California Economic Impact Report - Data Book
- The State of Innovation in Highly Prevalent Chronic Diseases 2019
- Animal testing in the United Kingdom
- The 2018 Genentech Oncology Trend Report
- 2018 PhRMA Annual Membership Survey
- Life Sciences Outlook United States 2017
- Global Participation in Clinical Trials Report 2015-2016
- 2015 Global life sciences outlook
Statistics on "Novartis"
- Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- R&D spending share of top pharmaceutical companies 2018 and 2024
- Net profit generated per employee in top pharmaceutical companies 2018
- Novartis' revenue 2007-2018
- Novartis' net income 2007-2018
- Dividends paid by Novartis AG 2009-2018
- Novartis' number of full-time employees 2009-2018
- Novartis revenue 2014-2018 by segment
- Novartis' revenue by region 2016-2018
- Novartis - revenue 2018 by segment and market
- Percentage of Novartis pharmaceuticals revenue by therapy area 2018
- Novartis' top drugs based on revenue 2018
- Novartis' expenditure on research and development 2004-2018
- Novartis' R&D expenditure as a percent of revenue 2004-2018
- Novartis' spending on research and development by division 2017-2018
- Patients reached by Novartis AG's products 2009-2018
- Novartis: ad spend in the U.S. 2012-2018
- Novartis' sales revenue in Spain 2012-2017
- Novartis' number of full-time employees by division 2013-2014
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by region
- Italy: clinical trials of Novartis approved by AIFA 2017, by stage
- Italy: investments of Novartis 2013-2017
- Italy: number of employees of Novartis 2017, by region
- Value of Novartis' pharmaceuticals exported from Spain 2012-2016
- Value of Novartis' investment in Spain 2012-2016
- Novartis' number of employees in Spain 2012-2017
- Novartis' R & D expenditure in Spain 2012-2016
- Genetic drugs: percentage of patents worldwide 2010
- LabCorp operating income 2013-2018
- Genentech: U.S. revenue by product 2008
- Remuneration of executive directors at GSK Pharmaceuticals in India FY 2018
- Software-defined storage market revenue 2016-2022
- Share in world imports of the leading food importers 2014, by country
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.